AAAAAA

   
Results: 1-10 |
Results: 10

Authors: Alexander, HR Libutti, SK Bartlett, DL Puhlmann, M Fraker, DL Bachenheimer, LC
Citation: Hr. Alexander et al., A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver, CLIN CANC R, 6(8), 2000, pp. 3062-3070

Authors: McCart, JA Puhlmann, M Lee, J Hu, Y Libutti, SK Alexander, HR Bartlett, DL
Citation: Ja. Mccart et al., Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression, GENE THER, 7(14), 2000, pp. 1217-1223

Authors: Puhlmann, M Brown, CK Gnant, M Huang, J Libutti, SK Alexander, HR Bartlett, DL
Citation: M. Puhlmann et al., Vaccinia as a vector for tumor-directed gene therapy: Biodistribution of athymidine kinase-deleted mutant, CANC GENE T, 7(1), 2000, pp. 66-73

Authors: Gnant, MFX Noll, LA Irvine, KR Puhlmann, M Terrill, RE Alexander, HR Bartlett, DL
Citation: Mfx. Gnant et al., Tumor-specific gene delivery using recombinant vaccinia virus in a rabbit model of liver metastases, J NAT CANC, 91(20), 1999, pp. 1744-1750

Authors: Bottcher, J Puhlmann, M Springob, G
Citation: J. Bottcher et al., Variability of sulfate sorption in a sandy Gleyic Podzol under a pine stand, J PLANT NU, 162(2), 1999, pp. 113-121

Authors: Puhlmann, M Gnant, M Brown, CK Alexander, HR Bartlett, DL
Citation: M. Puhlmann et al., Thymidine kinase-deleted vaccinia virus expressing purine nucleoside phosphorylase as a vector for tumor-directed gene therapy, HUM GENE TH, 10(4), 1999, pp. 649-657

Authors: Puhlmann, M Fink, U Siewert, JR
Citation: M. Puhlmann et al., Value of tumor debulking in gastrointestinal tumors, CHIRURG, 70(12), 1999, pp. 1408-1414

Authors: Gnant, MFX Berger, AC Huang, J Puhlmann, M Wu, PC Merino, MJ Bartlett, DL Alexander, HR Libutti, SK
Citation: Mfx. Gnant et al., Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus, CANCER RES, 59(18), 1999, pp. 4668-4674

Authors: Gnant, MFX Puhlmann, M Alexander, HR Bartlett, DL
Citation: Mfx. Gnant et al., Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice, CANCER RES, 59(14), 1999, pp. 3396-3403

Authors: Gnant, MFX Puhlmann, M Bartlett, DL Alexander, HR
Citation: Mfx. Gnant et al., Regional versus systemic delivery of recombinant vaccinia virus as suicidegene therapy for murine liver metastases, ANN SURG, 230(3), 1999, pp. 352-360
Risultati: 1-10 |